[Azithromycin in the therapy of lower respiratory tract infection in children].
Lower respiratory tract infections are serious health problem in pediatric population. The prevalence of infections is the highest in the youngest group and typical bacteria is the most common cause of diseases in this group. The role of atypical pathogens is on the rise in older patients. The choice of therapy depends on ethiology The article is focused on the role of azithromycin showing the benefits of such therapy.
Breborowicz
Anna
A
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Klinika Pneumonologii, Alergologii Dzieciecej i Immunologii Klinicznej III Katedry Pediatrii.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D006801:Humans; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D017963:Azithromycin